In the case of nonvalvular AF, the use of direct thrombin and factor Xa inhibitors, such as apixaban and rivaroxaban, may have less risk of intracranial hemorrhage than patients on warfarin [65]. The gene discussed is F10; the disease is intracranial hemorrhage.